JNJ
Johnson & Johnson
Price:  
157.25 
USD
Volume:  
10,217,905.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

JNJ EV/EBITDA

-30.4%
Upside

As of 2025-02-14, the EV/EBITDA ratio of Johnson & Johnson (JNJ) is 13.20. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. JNJ's latest enterprise value is 406,173.25 mil USD. JNJ's TTM EBITDA according to its financial statements is 30,760.00 mil USD. Dividing these 2 quantities gives us the above JNJ EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 7.4x - 8.4x 7.8x
Forward P/E multiples 12.9x - 17.1x 15.8x
Fair Price 83.60 - 142.66 109.42
Upside -46.8% - -9.3% -30.4%
157.25 USD
Stock Price
109.42 USD
Fair Price

JNJ EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-13 13.20
2025-02-12 13.05
2025-02-11 13.12
2025-02-10 12.97
2025-02-07 12.88
2025-02-06 12.91
2025-02-05 13.00
2025-02-04 12.91
2025-02-03 12.78
2025-01-31 12.81
2025-01-30 12.86
2025-01-29 12.73
2025-01-28 12.67
2025-01-27 12.86
2025-01-24 12.39
2025-01-23 12.37
2025-01-22 12.27
2025-01-21 12.49
2025-01-17 12.40
2025-01-16 12.46
2025-01-15 12.24
2025-01-14 12.23
2025-01-13 12.20
2025-01-10 12.02
2025-01-08 12.03
2025-01-07 12.34
2025-01-06 12.14
2025-01-03 12.18
2025-01-02 12.17
2024-12-31 12.22
2024-12-30 12.12
2024-12-27 12.25
2024-12-26 12.29
2024-12-24 12.31
2024-12-23 12.27
2024-12-20 12.20
2024-12-19 12.13
2024-12-18 12.23
2024-12-17 12.36
2024-12-16 12.16
2024-12-13 12.37
2024-12-12 12.34
2024-12-11 12.37
2024-12-10 12.58
2024-12-09 12.61
2024-12-06 12.58
2024-12-05 12.60
2024-12-04 12.67
2024-12-03 12.82
2024-12-02 13.01